Mary McNamara-Cullinane
General Counsel bei CLEARPOINT NEURO, INC.
Profil
Mary McNamara-Cullinane is currently the Vice President-Regulatory Affairs at Clearpoint Neuro, Inc. She previously worked as the Director-Regulatory Affairs & Quality Assurance at Molecular Biometrics, Inc. and as the Vice President-Regulatory & Clinical Affairs at Echo Therapeutics, Inc. Ms. McNamara-Cullinane obtained an undergraduate degree from Massachusetts College of Liberal Arts.
Aktive Positionen von Mary McNamara-Cullinane
| Unternehmen | Position | Beginn |
|---|---|---|
| CLEARPOINT NEURO, INC. | General Counsel | 08.08.2022 |
Ehemalige bekannte Positionen von Mary McNamara-Cullinane
| Unternehmen | Position | Ende |
|---|---|---|
Molecular Biometrics, Inc.
 Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA. | General Counsel | - |
| ECHO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Mary McNamara-Cullinane
| Massachusetts College of Liberal Arts | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CLEARPOINT NEURO, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Molecular Biometrics, Inc.
Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA. | Commercial Services |
Echo Therapeutics, Inc.
 Echo Therapeutics, Inc. Medical SpecialtiesHealth Technology Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ. | Health Technology |
